17-17866341-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001082968.2(TOM1L2):āc.1039A>Gā(p.Asn347Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,612,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001082968.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOM1L2 | NM_001082968.2 | c.1039A>G | p.Asn347Asp | missense_variant | 10/15 | ENST00000379504.8 | NP_001076437.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOM1L2 | ENST00000379504.8 | c.1039A>G | p.Asn347Asp | missense_variant | 10/15 | 2 | NM_001082968.2 | ENSP00000368818 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000812 AC: 2AN: 246294Hom.: 0 AF XY: 0.00000751 AC XY: 1AN XY: 133088
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459978Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726038
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.1039A>G (p.N347D) alteration is located in exon 10 (coding exon 10) of the TOM1L2 gene. This alteration results from a A to G substitution at nucleotide position 1039, causing the asparagine (N) at amino acid position 347 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at